MRNA Oct 2022 145.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 10:11AM EDT. Market open.
| Previous close | 38.52 |
| Open | 38.52 |
| Bid | 37.20 |
| Ask | 38.35 |
| Strike | 145.00 |
| Expiry date | 2022-10-21 |
| Day's range | 38.52 - 38.52 |
| Contract range | N/A |
| Volume | |
| Open interest | 91 |
- Editor's pickYahoo Finance Video
Stocks gaining in early trading: Nvidia, AMD, Tesla, Moderna, Gilead
Yahoo Finance Live’s Brad Smith breaks down how stocks are moving in early trading.
- Financial Times
UK becomes first country to approve Omicron-specific Covid booster
Moderna’s two-strain shot will target both the original strain and BA.1 in step with European regulators
- Bloomberg
UK Takes World’s First Step Toward Omicron-Tailored Shot
(Bloomberg) -- The UK has granted the world’s first approval for a Covid-19 vaccine targeting a variant in a bid to sharpen its response to an evolving coronavirus. The country’s Medicines and Healthcare products Regulatory Agency cleared Moderna Inc.’s bivalent mRNA booster vaccine for adults, according to a statement Monday, in a move paving the way for it to potentially form part of Britain’s autumn booster campaign.Moderna’s bivalent shot targets two strains - half of the dose works against
© 2022 Yahoo. All rights reserved.
